All Curated Mutation Sites in MARV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in MARV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
VP40
  
VP35
  
VP30
  
L
  

ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 21289122 D184N
VP40
VP40
Marburg Virus Infection
R
S
I
View
2 21289122 Y19H
VP40
VP40
Marburg Virus Infection
R
S
I
View
3 21325424 T165A
VP40
VP40
Cell line
G
R
T
View
4 21325424 V57A
VP40
VP40
Cell line
G
R
T
View
5 21325424 H7Y
VP40
VP40
Cell line
G
R
T
View
6 21325424 H19Y
VP40
VP40
Cell line
G
R
T
View
7 21325424 A165T
VP40
VP40
Cell line
G
R
T
View
8 21325424 N184D
VP40
VP40
Cell line
G
R
T
View
9 21325424 S189N
VP40
VP40
Cell line
G
R
T
View
10 21325424 A190T
VP40
VP40
Cell line
G
R
T
View
11 26581998 D184N
VP40
VP40
Cell line
G
R
T
View
12 35997284 C92S
VP30
VP30
Cell line
R
S
View
13 35997284 H96L
VP30
VP30
Cell line
R
S
View
14 24459115 F228A
VP35
VP35

R
View
15 24459115 K298A
VP35
VP35

R
View
16 24459115 R271A
VP35
VP35

R
View
17 27450090 A759D
L
L

R
View
18 27450090 D184N
VP40
VP40

View
19 27450090 D758A
L
L

R
View
20 27450090 S741C
L
L

R
View
Contents
Description

The table shows all curated mutation sites of MARV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.